A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer.

Seminars in oncology

Volumn 24, Issue 4 Suppl 12, 1997, Pages

  Rosell, R ^a   Felip, E ^a   Massuti, B ^a   Gonzalez Larriba J L ^a   Benito, D ^a   Lopez Cabrerizo M P ^a   Salamanca, O ^a   Camps, C ^a   Puerto Pica, J ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ETOPOSIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; PHASE 2 CLINICAL TRIAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL;

EID: 0031203248     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)